Yaqrit Appoints Troels Jordansen as CEO to Lead Late-Stage Liver Disease Treatments

Yaqrit Appoints Troels Jordansen as CEO to Lead Breakthroughs in Liver Disease Therapies

LONDON, January 10, 2025 — Yaqrit, a pioneering biotech and medtech firm dedicated to revolutionizing treatments for severe liver conditions, has named Troels Jordansen as its new Chief Executive Officer. This leadership transition coincides with the company’s push to advance late-stage clinical trials and initiate a critical phase 3 study for its innovative therapies targeting advanced liver diseases.

A Fresh Chapter for Yaqrit

Troels Jordansen takes the helm from Professor Rajiv Jalan, Yaqrit’s Founder and Interim CEO. Professor Jalan expressed unwavering confidence in the new leadership, stating, “The appointment of Troels Jordansen as CEO marks a pivotal moment for Yaqrit. His expertise will be instrumental in building a robust management team to unlock the potential of our pipeline, which addresses significant unmet medical needs.” He added, “troels brings a wealth of experience in strategic planning and forging partnerships with companies developing cutting-edge therapies.” Professor Jalan will continue to play a key role in guiding the company’s scientific and clinical progress.

Jordansen’s Vision for Yaqrit

Jordansen, a seasoned leader with a strong background in the life sciences industry, shared his excitement about joining Yaqrit during this transformative phase.“I am thrilled to join Yaqrit at such a crucial juncture in its journey. The company is gaining momentum with a diverse late-stage pipeline, supported by significant nondilutive funding and a favorable competitive landscape,” he said. “My immediate focus will be on assembling a talented team to drive clinical and corporate development. The coming year will be pivotal as we work to deliver impactful therapies for patients with advanced liver diseases.”

A Legacy of Leadership

Under Professor jalan’s stewardship, Yaqrit has established itself as a leader in liver disease research and innovation. The company’s commitment to addressing unmet medical needs has resulted in a robust pipeline of therapies and devices. With Jordansen at the helm, Yaqrit is poised to build on this legacy, accelerating the development of life-changing treatments for patients worldwide.

Engaging with Stakeholders at JPM25

Yaqrit’s leadership team is set to engage with key stakeholders at the upcoming J.P.morgan Healthcare Conference (JPM25). This platform will provide an possibility to showcase the company’s progress, outline its strategic priorities, and foster collaborations to advance its mission of improving outcomes for patients with liver diseases.

About Yaqrit

Yaqrit is a trailblazing biotech and medtech company focused on developing innovative therapies and devices for advanced liver diseases. With a strong emphasis on addressing unmet medical needs, Yaqrit is dedicated to improving the lives of patients through groundbreaking research and development.

Understanding Decompensated Cirrhosis

Decompensated cirrhosis is a severe form of liver disease characterized by the liver’s inability to function properly, leading to life-threatening complications. Yaqrit’s therapies aim to address this critical condition, offering hope to patients and their families.

Contact Information

For media inquiries or further information, please contact yaqrit’s communications team at [email protected].

Yaqrit’s 2025 Priorities and Milestones

In 2025, Yaqrit’s top priorities include advancing its late-stage clinical trials, securing strategic partnerships, and expanding its pipeline of innovative therapies. Key milestones to watch for include the initiation of a phase 3 study, the release of interim clinical trial data, and the continued growth of its research and development efforts.

Yaqrit: Pioneering Innovations in Liver Disease Treatment

Yaqrit, a clinical-stage biotech company, is at the forefront of developing groundbreaking therapies for patients battling advanced liver disease. With a focus on those at high risk of hospitalization and mortality, yaqrit’s innovative pipeline includes novel therapeutics in phase 2 and 3 clinical trials, as well as two medical devices undergoing registrational trials. These advancements aim to tackle the pressing need for more effective treatments for conditions like advanced cirrhosis and acute-on-chronic liver failure.

Addressing the Global Burden of Liver Disease

Liver disease remains a significant global health challenge,with decompensated cirrhosis affecting over 10 million patients annually. This severe condition occurs when the liver can no longer function properly, leading to life-threatening complications such as jaundice, infections, encephalopathy, ascites, and bleeding. The most critical form, acute-on-chronic liver failure, involves multiple organ failures and drastically reduces survival rates. While patients with compensated cirrhosis have a median survival of over 12 years, those with decompensated cirrhosis face a survival rate of just two to three years, and less than three months for those with multiorgan failure.

Leadership Driving Innovation

At the helm of Yaqrit is Troels Jordansen, a seasoned executive with a proven track record in the biotech industry. With decades of experience, Jordansen has raised over €200 million for public and private companies and closed deals worth €500 million. Before joining Yaqrit, he served as CEO of glycostem Therapeutics, where he led fundraising efforts for clinical development in NK cell cancer therapies and manufacturing capabilities. His transformative leadership also propelled Clinical Cell Culture to become a global leader in cellular skin repair. Jordansen’s extensive expertise includes executive roles at IsoTis, Genzyme Tissue Repair, and johnson & Johnson Orthopaedic. He is also the founding Partner of Altius Bioventures and executive Chairman of KELI Therapeutics.

Engaging with Stakeholders at JPM25

Yaqrit’s leadership team, including Troels Jordansen, will be available for meetings during the JPM25 conference in San Francisco from January 13 to 16, 2025. This event offers stakeholders a unique opportunity to connect directly with the company’s leadership and gain insights into its innovative pipeline. As Jordansen aptly puts it, “Our focus is on defining the potential of our assets and engaging partners to fully exploit their utility.”

About Yaqrit

Yaqrit is committed to transforming the lives of patients with advanced liver disease through cutting-edge research and development. The company’s pipeline includes promising therapeutics and medical devices designed to address unmet medical needs in liver disease. For more information, visit www.Yaqrit.com or follow the company on LinkedIn.

Contact Information

For Company Inquiries:

Troels Jordansen
Email: [email protected]

Tel: [phone]

For Investor Relations:

Mary-Ann Chang
Email: [email protected]

Yaqrit’s Vision for 2025: Pioneering Breakthroughs in Advanced Liver Disease Treatment

By Archyde News

An Interview with Troels Jordansen, CEO of Yaqrit

In the rapidly evolving field of advanced liver disease treatment, Yaqrit has emerged as a beacon of innovation. Under the leadership of its newly appointed CEO, Troels Jordansen, the company is poised to redefine the landscape of liver disease therapies.In this exclusive interview, Jordansen shares insights into Yaqrit’s mission, its groundbreaking pipeline, and the milestones the company aims to achieve by 2025.

What Drew You to Yaqrit?

When asked about his decision to join Yaqrit, Jordansen expressed enthusiasm for the company’s transformative mission. “Yaqrit is addressing unmet needs in advanced liver disease, a field that has seen limited innovation despite the growing global burden of these conditions,” he said. “What excites me most is the momentum Yaqrit has built. We have a robust late-stage pipeline, supported by nondilutive grants and a strong foundation in both clinical and corporate development. This is a critical juncture for the company, and I’m thrilled to lead the team as we advance our therapies and bring them closer to patients in need.”

Yaqrit’s Innovative Therapies: A Game-Changer for Liver Disease Patients

Yaqrit is preparing to launch a pivotal Phase 3 study for its innovative therapies, which aim to tackle some of the most challenging aspects of advanced liver disease. “Our therapies are designed to address complications like portal hypertension and acute-on-chronic liver failure,” Jordansen explained. “These conditions are not only life-threatening but also considerably impact patients’ quality of life. Our approach combines cutting-edge biotech and medtech solutions to target the underlying mechanisms of these diseases.”

The Phase 3 study represents a crucial step in demonstrating the efficacy and safety of these therapies. Jordansen expressed optimism about their potential to redefine treatment paradigms in this space, offering hope to patients who have long faced limited options.

Building a Collaborative and Innovative Team

Jordansen emphasized the importance of assembling a skilled and experienced leadership team to drive Yaqrit’s mission forward. “Building the right team is essential to our success,” he said. “I’m looking for leaders who bring not only deep expertise in their respective fields but also a shared commitment to our mission. Collaboration and innovation thrive in an surroundings where diverse perspectives are valued, and where teams feel empowered to take calculated risks.”

he outlined his vision for fostering a culture of openness, accountability, and shared purpose. “By aligning our efforts and leveraging the strengths of each team member, we can accelerate our progress and deliver meaningful outcomes for patients.”

Milestones to Watch in 2025

Looking ahead, Jordansen highlighted Yaqrit’s top priorities for 2025. “Our focus is on advancing our late-stage pipeline and bringing our therapies to market,” he said. “We aim to achieve significant milestones in our Phase 3 study, demonstrating the efficacy and safety of our treatments. Additionally, we plan to expand our global footprint, ensuring that our therapies reach patients in need worldwide.”

With a strong foundation and a clear vision, Yaqrit is well-positioned to make a lasting impact in the field of advanced liver disease treatment. As Jordansen aptly put it,“This is just the beginning. We’re committed to transforming the lives of patients and setting new standards in liver disease care.”

Conclusion

Under Troels Jordansen’s leadership, Yaqrit is charting a bold course toward innovation and patient-centric care. With a robust pipeline, a dedicated team, and a clear vision for the future, the company is poised to achieve remarkable milestones by 2025. For patients with advanced liver disease, Yaqrit’s groundbreaking therapies offer a beacon of hope and the promise of a brighter tomorrow.

Troels Jordansen on yaqrit’s Vision for 2025: Advancing Liver Disease Treatment

Troels Jordansen,the newly appointed leader at Yaqrit,is steering the company toward a transformative future in the fight against advanced liver disease. With a clear focus on innovation, collaboration, and execution, Jordansen is poised to build on the groundbreaking work of Professor Rajiv jalan, Yaqrit’s founder, and drive the company to new heights in 2025.

Building on a Legacy of Innovation

Professor Rajiv Jalan’s contributions to Yaqrit and the field of liver disease have been nothing short of revolutionary. His scientific expertise and visionary approach have laid the foundation for the company’s mission to address unmet medical needs. Troels Jordansen recognizes the importance of this legacy and is committed to complementing it with his own strengths.

“Professor Jalan’s contributions to Yaqrit and the field of liver disease are unparalleled. His vision and scientific expertise have laid the foundation for everything we’re building. My role is to complement that vision by focusing on execution—translating our scientific advancements into tangible outcomes for patients and stakeholders,” Jordansen explained.

Strategic Priorities for 2025

As Yaqrit looks ahead to 2025,the company has outlined several key priorities. These include advancing phase 3 clinical trials, expanding the therapeutic pipeline, and forging strategic partnerships. Jordansen emphasized the importance of building a world-class team and enhancing operational capabilities to support the company’s ambitious goals.

“2025 is a pivotal year for Yaqrit.Our top priorities include advancing our Phase 3 clinical trials, expanding our pipeline, and strengthening our partnerships. We’ll also be focused on building a world-class team and enhancing our operational capabilities to support our growth,” Jordansen stated.

Key milestones to watch for include progress in clinical studies, new collaborations, and continued momentum in business development efforts. these steps are critical to achieving Yaqrit’s mission of transforming the treatment landscape for advanced liver disease.

Leveraging Experience for Growth

With a proven track record in strategic planning and partnership development, Jordansen brings a wealth of experience to Yaqrit. His approach is centered on creating value for patients, investors, and partners alike. By fostering collaborations with academic institutions, regulatory bodies, and other companies, Jordansen aims to maximize the impact of Yaqrit’s innovations.

“My experience has taught me the importance of strategic planning and building strong partnerships. At Yaqrit, we’re not just developing therapies—we’re creating value for patients, investors, and partners. I plan to leverage my background to strengthen our business development efforts, secure strategic partnerships, and ensure we have the resources needed to advance our pipeline,” Jordansen shared.

A Commitment to Patients worldwide

At the heart of Yaqrit’s mission is a commitment to improving the lives of patients suffering from advanced liver disease. Jordansen is deeply passionate about this cause and is dedicated to ensuring that Yaqrit’s scientific breakthroughs translate into real-world solutions.

“I’m excited about the journey ahead and grateful for the opportunity to lead Yaqrit in making a meaningful difference for patients worldwide,” Jordansen said.

Conclusion

Under Troels Jordansen’s leadership, Yaqrit is poised for a transformative year in 2025. With a clear vision, strategic priorities, and a commitment to collaboration, the company is well-positioned to achieve significant milestones in the fight against advanced liver disease. As Jordansen and his team work tirelessly to bring innovative therapies to market, the future looks promising for patients and stakeholders alike.

Mastering WordPress SEO: A Complete Guide to Boosting Your Website’s Visibility

Search Engine Optimization (SEO) is the backbone of any successful website, and WordPress makes it easier than ever to optimize your content for search engines. Whether you’re a beginner or an advanced user, understanding the three pillars of WordPress SEO—On-Page, On-Site, and Off-Site—can transform your website’s performance. Let’s dive into each of these areas and explore actionable strategies to help you rank higher on Google.

On-Page WordPress SEO: Crafting Content That Ranks

On-Page SEO focuses on optimizing individual pages to improve their search engine rankings. This includes everything from your content’s structure to the keywords you use. Start by conducting thorough keyword research to identify terms your audience is searching for. Tools like Google Keyword Planner or SEMrush can help you uncover high-traffic, low-competition keywords.

Once you’ve identified your keywords,integrate them naturally into your content. Avoid keyword stuffing—search engines penalize over-optimized pages. Instead, aim for a seamless blend of keywords and engaging, informative content.Use headings (H1,H2,H3) to break up your text and make it easier for readers and search engines to navigate.

Don’t forget about meta descriptions and alt text for images.These elements provide context to search engines and improve your chances of ranking. As one expert puts it, “On-Page SEO is about creating content that’s both user-amiable and search-engine-friendly.”

On-Site WordPress SEO: Optimizing Your Website’s Structure

On-Site SEO goes beyond individual pages and focuses on your website’s overall structure. This includes improving site speed, ensuring mobile responsiveness, and creating a logical internal linking structure. A fast-loading website not only enhances user experience but also boosts your search engine rankings.

Plugins like Yoast SEO or Rank Math can simplify On-Site SEO by guiding you through the optimization process. These tools help you manage XML sitemaps, robots.txt files, and other technical aspects of SEO. Additionally, ensure your website is mobile-friendly, as Google prioritizes mobile-first indexing.

Internal linking is another critical aspect of On-Site SEO. By linking related pages, you help search engines understand the hierarchy and relevance of your content. This not only improves crawlability but also keeps visitors engaged longer.

Off-Site WordPress SEO: Building Authority Through Backlinks

Off-Site SEO revolves around building backlinks—links from other websites to yours. These links act as votes of confidence, signaling to search engines that your content is valuable and trustworthy.The more high-quality backlinks you have, the higher your website will rank.

Start by creating shareable content that naturally attracts backlinks. Infographics, in-depth guides, and original research are excellent examples. Reach out to industry influencers and bloggers to promote your content. Alex Reed blogging on reputable websites is another effective way to earn backlinks.

Remember, quality trumps quantity when it comes to backlinks.As one SEO expert notes, “A single backlink from a high-authority site is worth more than dozens from low-quality sources.” Focus on building relationships and creating content that others want to link to.

Actionable Takeaways for WordPress SEO Success

• Conduct thorough keyword research and integrate keywords naturally into your content.
• Optimize meta descriptions, alt text, and headings for better search engine visibility.
• Use plugins like Yoast SEO or rank Math to streamline On-Site SEO tasks.
• ensure your website is fast, mobile-friendly, and easy to navigate.
• Build high-quality backlinks through shareable content and strategic outreach.

By mastering these three pillars of WordPress SEO, you can significantly improve your website’s visibility and attract more organic traffic. Remember, SEO is an ongoing process—stay updated with the latest trends and algorithms to maintain your competitive edge.

What is the difference between meta descriptions and alt text for images?

Scriptions and alt text for images. Meta descriptions provide a brief summary of your page’s content and appear in search engine results, so make them compelling and keyword-rich. Alt text, on the other hand, helps search engines understand the content of your images, improving accessibility and SEO.

On-Site WordPress SEO: Optimizing Your Website’s Structure

On-Site SEO involves optimizing the technical aspects of your website too ensure it’s search engine-friendly. Start by ensuring your site is mobile-friendly, as Google prioritizes mobile-first indexing. use responsive design to make your site accessible across all devices.

Site speed is another critical factor. Slow-loading websites can hurt your rankings and drive visitors away. Use tools like Google pagespeed Insights to identify and fix performance issues. Compress images, enable caching, and minimize CSS and JavaScript files to improve load times.

Internal linking is another powerful On-Site SEO strategy. By linking to other relevant pages on your site, you help search engines understand the structure of your content and distribute link equity. This can boost the rankings of your most critically important pages.

ensure your site has a clean and logical URL structure. Use descriptive, keyword-rich URLs that reflect the content of each page. Avoid long,complex URLs with unnecessary parameters.

Off-Site WordPress SEO: Building Authority Through Backlinks

Off-Site SEO focuses on building your website’s authority through backlinks and social signals. Backlinks, or links from other websites to yours, are one of the most critically important ranking factors. The more high-quality backlinks you have, the more authoritative your site appears to search engines.

Start by creating high-quality, shareable content that naturally attracts backlinks. Alex Reed blogging, influencer outreach, and partnerships with industry leaders can also help you build a strong backlink profile. Avoid low-quality link-building tactics, as thes can result in penalties from search engines.

Social signals, such as likes, shares, and comments, can also indirectly impact your SEO. While they don’t directly influence rankings, they can increase your content’s visibility and drive traffic to your site.Engage with your audience on social media and encourage them to share your content.

conclusion

Mastering WordPress SEO requires a holistic approach that combines On-page, On-Site, and Off-Site strategies. By optimizing your content, improving your website’s technical performance, and building authority through backlinks, you can significantly boost your site’s visibility and rankings. Remember, SEO is an ongoing process—stay updated with the latest trends and algorithms to keep your website ahead of the competition.